Cargando…

Multivariate analyses of immune markers reveal increases in plasma EN-RAGE in first-episode psychosis patients

Immune cells and cytokines are largely recognized as significant factors in the pathophysiology of neuropsychiatric disorders. The possible role of other blood cells such as leukocytes in events of acute psychosis is in contrast only emerging. To study blood-born markers in acute psychosis we here e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Korhonen, Laura, Paul, Elisabeth R., Wåhlén, Karin, Haring, Liina, Vasar, Eero, Vaheri, Antti, Lindholm, Dan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10589203/ https://www.ncbi.nlm.nih.gov/pubmed/37863883 http://dx.doi.org/10.1038/s41398-023-02627-8

Ejemplares similares

Taurine and Epidermal Growth Factor Belong to the Signature of First-Episode Psychosis
por: Koido, Kati, et al.
Publicado: (2016)

Antipsychotic Treatment Reduces Indices of Oxidative Stress in First-Episode Psychosis Patients
por: Kriisa, Kärt, et al.
Publicado: (2016)

Profiling of Amino Acids and Their Derivatives Biogenic Amines Before and After Antipsychotic Treatment in First-Episode Psychosis
por: Leppik, Liisa, et al.
Publicado: (2018)

A Marked Low-Grade Inflammation and a Significant Deterioration in Metabolic Status in First-Episode Schizophrenia: A Five-Year Follow-Up Study
por: Parksepp, Madis, et al.
Publicado: (2022)

The Expanded Endocannabinoid System Contributes to Metabolic and Body Mass Shifts in First-Episode Schizophrenia: A 5-Year Follow-Up Study
por: Parksepp, Madis, et al.
Publicado: (2022)

Metabolomics approach revealed robust changes in amino acid and biogenic amine signatures in patients with schizophrenia in the early course of the disease
por: Parksepp, Madis, et al.
Publicado: (2020)

Differential patterns of cross-reactive antibody response against SARS-CoV-2 spike protein detected for chronically ill and healthy COVID-19 naïve individuals
por: Jaago, Mariliis, et al.
Publicado: (2022)

Metabolic profile associated with distinct behavioral coping strategies of 129Sv and Bl6 mice in repeated motility test
por: Narvik, Jane, et al.
Publicado: (2018)

S170. AMYGDALA SUBNUCLEI VOLUMES IN FIRST-EPISODE PSYCHOSIS: ASSOCIATION WITH CHILDHOOD ADVERSITY
por: Armio, Reetta-Liina, et al.
Publicado: (2018)

Repeated Administration of D-Amphetamine Induces Distinct Alterations in Behavior and Metabolite Levels in 129Sv and Bl6 Mouse Strains
por: Vanaveski, Taavi, et al.
Publicado: (2018)

Thermal Pain Thresholds Are Significantly Associated with Plasma Proteins of the Immune System in Chronic Widespread Pain—An Exploratory Pilot Study Using Multivariate and Network Analyses
por: Gerdle, Björn, et al.
Publicado: (2021)

S132. SAMPLING BIAS IN STUDIES OF FIRST-EPISODE PSYCHOSIS – A FOLLOW-UP STUDY
por: Walta, Maija, et al.
Publicado: (2020)

Plasma bilirubin levels are reduced in first-episode psychosis patients and associates to working memory and duration of untreated psychosis
por: Becklén, Meneca, et al.
Publicado: (2021)

Association of plasma sRAGE, but not esRAGE with lung function impairment in COPD
por: Gopal, Poornima, et al.
Publicado: (2014)

Reduced Mismatch Negativity is Associated with Increased Plasma Level of Glutamate in First-episode Psychosis
por: Nagai, Tatsuya, et al.
Publicado: (2017)

Plasma Apelin, Visfatin and Resistin Levels in Patients with First Episode Psychosis and Chronic Schizophrenia
por: Sahpolat, Musa, et al.
Publicado: (2020)

Natural Language Processing markers in first episode psychosis and people at clinical high-risk
por: Morgan, Sarah E., et al.
Publicado: (2021)

Multivariate Relationships Between Peripheral Inflammatory Marker Subtypes and Cognitive and Brain Structural Measures in Psychosis
por: Lizano, Paulo, et al.
Publicado: (2020)

Functional neuroimaging in first-episode psychosis
por: Gheorghe, Mihai D., et al.
Publicado: (2005)

Clinical Recovery in First-Episode Psychosis
por: Wunderink, Lex, et al.
Publicado: (2009)

Treatment Principles of First-Episode Psychosis
por: ÜÇOK, Alp
Publicado: (2021)

The Role of the Microbiome in First Episode of Psychosis
por: Nuncio-Mora, Lucero, et al.
Publicado: (2023)

Digital Psychoeducation for First Episode Psychosis
por: Ahmedani, Iman, et al.
Publicado: (2023)

The Three Subtypes of Tick-Borne Encephalitis Virus Induce Encephalitis in a Natural Host, the Bank Vole (Myodes glareolus)
por: Tonteri, Elina, et al.
Publicado: (2013)

Polygenic risk score analyses of symptoms and treatment response in an antipsychotic-naive first episode of psychosis cohort
por: Santoro, Marcos Leite, et al.
Publicado: (2018)

Plasma amino acids profile in first-episode psychosis, unaffected siblings and community-based controls
por: Loureiro, Camila Marcelino, et al.
Publicado: (2020)

Peptidomic characterization of peptide processing in the hippocampus of Wfs1 knockout mice
por: Tein, Karin, et al.
Publicado: (2015)

Environmental Change and Disease Dynamics: Effects of Intensive Forest Management on Puumala Hantavirus Infection in Boreal Bank Vole Populations
por: Voutilainen, Liina, et al.
Publicado: (2012)

Violence in first-episode psychosis: evidence from an early intervention in psychosis programme
por: Mentxaka, Oihane, et al.
Publicado: (2023)

Reinforcement and Reversal Learning in First-Episode Psychosis
por: Murray, G. K., et al.
Publicado: (2008)

White-matter hyperintensities in first-episode psychosis
por: Zanetti, Marcus V., et al.
Publicado: (2008)

Complement system biomarkers in first episode psychosis
por: Kopczynska, Maja, et al.
Publicado: (2019)

Is It Possible to Predict the Future in First-Episode Psychosis?
por: Suvisaari, Jaana, et al.
Publicado: (2018)

Cardiometabolic Risk in First Episode Psychosis Patients
por: Smith, Jo, et al.
Publicado: (2020)

Prescribing differently for women with first-episode psychosis
por: Sabesan, Priyadharshini, et al.
Publicado: (2021)

Abnormal Brain Bioenergetics in First-Episode Psychosis
por: Yuksel, Cagri, et al.
Publicado: (2021)

Quality of life in patients with the first-episode psychosis
por: Usova, A., et al.
Publicado: (2021)

Clozapine in First Episode Psychosis: The best is delayed
por: Rodrigues, J. B., et al.
Publicado: (2023)

Assessment of EN-RAGE, sRAGE and EN-RAGE/sRAGE as potential biomarkers in patients with autoimmune hepatitis
por: Wu, Rui, et al.
Publicado: (2020)

Plasma brain-derived neurotrophic factor levels, learning capacity and cognition in patients with first episode psychosis
por: de Azua, Sonia Ruiz, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_fkjll1at3u3745mojvf0j2c80d